Literature DB >> 11722643

Granule-dependent killing of Toxoplasma gondii by CD8+ T cells.

Y Nakano1, H Hisaeda, T Sakai, M Zhang, Y Maekawa, T Zhang, M Nishitani, H Ishikawa, K Himeno.   

Abstract

Immunization of mice with live bradyzoites of a low-virulent Beverley strain of Toxoplasma gondii has been shown to increase CD8+ T-cell mediated immunity against a highly virulent RH strain. We found that preimmunization with an RH homogenate further enhanced this immunity. Using this model, we investigated the mechanism of CD8+ T-cell mediated protection against T. gondii infection. Splenic cells from mice immunized with RH homogenate and live bradyzoites stimulated apoptosis of RH-infected J774A.1 macrophages in vitro, and at the same time, the immunization significantly suppressed the proliferation of parasites within macrophages, as assessed by measuring 3H-uracil uptake by the parasites. Splenic cells from the immunized mice produced larger amounts of interferon-gamma (IFN-gamma) than did naive splenic cells; however, the production of nitric oxide (NO) by RH-infected macrophages was not enhanced. The elimination of CD8+ T cells from splenic cells significantly reduced their inhibitory action on parasite proliferation as well as their cytotoxic activity against RH-infected macrophages, but it did not affect the production of IFN-gamma. Treatment of CD8+ T-enriched splenic cells from the immunized mice with concanamycin A, but not an anti-Fas ligand monoclonal antibody, significantly reduced their anti-proliferative and killing capabilities, suggesting that the CD8+ T cells induced by immunization with RH antigen and live bradyzoites of the Beverley strain may exert protection against T. gondii infection at least in part through granule-dependent cytotoxic activities.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11722643      PMCID: PMC1783309          DOI: 10.1046/j.1365-2567.2001.01319.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  48 in total

1.  The JAM test. A simple assay for DNA fragmentation and cell death.

Authors:  P Matzinger
Journal:  J Immunol Methods       Date:  1991-12-15       Impact factor: 2.303

2.  Role of L3T4+ and Lyt-2+ T cell subsets in protective immune responses of mice against infection with a low or high virulent strain of Toxoplasma gondii.

Authors:  H Nagasawa; T Manabe; Y Maekawa; M Oka; K Himeno
Journal:  Microbiol Immunol       Date:  1991       Impact factor: 1.955

3.  IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha.

Authors:  J A Langermans; M E Van der Hulst; P H Nibbering; P S Hiemstra; L Fransen; R Van Furth
Journal:  J Immunol       Date:  1992-01-15       Impact factor: 5.422

4.  Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide.

Authors:  F Y Liew; Y Li; S Millott
Journal:  J Immunol       Date:  1990-12-15       Impact factor: 5.422

5.  Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine.

Authors:  L B Adams; J B Hibbs; R R Taintor; J L Krahenbuhl
Journal:  J Immunol       Date:  1990-04-01       Impact factor: 5.422

6.  Induction of heat shock protein closely correlates with protection against Toxoplasma gondii infection.

Authors:  H Nagasawa; M Oka; K Maeda; C Jian-Guo; H Hisaeda; Y Ito; R A Good; K Himeno
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

7.  CD8+ T cells are the major lymphocyte subpopulation involved in the protective immune response to Toxoplasma gondii in mice.

Authors:  S J Parker; C W Roberts; J Alexander
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

8.  Antigen-specific (p30) mouse CD8+ T cells are cytotoxic against Toxoplasma gondii-infected peritoneal macrophages.

Authors:  L H Kasper; I A Khan; K H Ely; R Buelow; J C Boothroyd
Journal:  J Immunol       Date:  1992-03-01       Impact factor: 5.422

9.  Murine CD8+ cytotoxic T lymphocytes lyse Toxoplasma gondii-infected cells.

Authors:  C S Subauste; A H Koniaris; J S Remington
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

10.  CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells.

Authors:  F T Hakim; R T Gazzinelli; E Denkers; S Hieny; G M Shearer; A Sher
Journal:  J Immunol       Date:  1991-10-01       Impact factor: 5.422

View more
  5 in total

Review 1.  Direct microbicidal activity of cytotoxic T-lymphocytes.

Authors:  Paul Oykhman; Christopher H Mody
Journal:  J Biomed Biotechnol       Date:  2010-06-23

2.  Neospora caninum-infected cattle develop parasite-specific CD4+ cytotoxic T lymphocytes.

Authors:  Lauren M Staska; Travis C McGuire; Christopher J Davies; Harris A Lewin; Timothy V Baszler
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

Review 3.  A Deep Insight Into Regulatory T Cell Metabolism in Renal Disease: Facts and Perspectives.

Authors:  Zhongyu Han; Kuai Ma; Hongxia Tao; Hongli Liu; Jiong Zhang; Xiyalatu Sai; Yunlong Li; Mingxuan Chi; Qing Nian; Linjiang Song; Chi Liu
Journal:  Front Immunol       Date:  2022-02-17       Impact factor: 7.561

4.  Predominant role of interferon-γ in the host protective effect of CD8(+) T cells against Neospora caninum infection.

Authors:  Alexandra Correia; Pedro Ferreirinha; Sofia Botelho; Ana Belinha; Catarina Leitão; Íris Caramalho; Luzia Teixeira; África González-Fernandéz; Rui Appelberg; Manuel Vilanova
Journal:  Sci Rep       Date:  2015-10-09       Impact factor: 4.379

5.  DNA vaccination with a gene encoding Toxoplasma gondii Deoxyribose Phosphate Aldolase (TgDPA) induces partial protective immunity against lethal challenge in mice.

Authors:  Ibrahim A Hassan; Shuai Wang; LiXin Xu; RuoFeng Yan; XiaoKai Song; Xiangrui Li
Journal:  Parasit Vectors       Date:  2014-09-08       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.